Ganglioside GM2

Ganglioside GM2 is a lipid of Sphingolipids (SP) class. Ganglioside gm2 is associated with abnormalities such as Sensory neuropathy, Neuropathy, Autoimmune Diseases, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating and Neuromuscular Diseases. The involved functions are known as Pressure- physical agent, Cytolysis, Inflammation, Complement-Dependent Cytotoxicity and conjugation. Ganglioside gm2 often locates in Membrane, Entire nervous system, Cell surface, Biopsy sample and Lipid Bilayers. The associated genes with Ganglioside GM2 are anti-IgM, Polypeptides, Transgenes, Alleles and Homologous Gene. The related lipids are Ganglioside GA2, QS 21, sulfate-3-glucuronyl paragloboside, Lipopolysaccharides and IV(4)-galactosyl-N-acetylganglioside GD1a. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Ganglioside GM2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Ganglioside GM2?

Ganglioside GM2 is suspected in Tay-Sachs Disease, Gangliosidoses GM2, Sandhoff Disease, Neuropathy, Cytomegalovirus Infections, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Ganglioside GM2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Ganglioside GM2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Ganglioside GM2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Ganglioside GM2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Ganglioside GM2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Ganglioside GM2?

Disease model

Disease model are used in the study 'Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.' (Ho CW et al., 2010) and Disease model are used in the study 'Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.' (Tsuji D et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Ganglioside GM2

Download all related citations
Per page 10 20 50 100 | Total 558
Authors Title Published Journal PubMed Link
Burg J et al. Mapping of the gene coding for the human GM2 activator protein to chromosome 5. 1985 Ann. Hum. Genet. pmid:3865618
Navon R et al. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A. 1985 Am. J. Hum. Genet. pmid:3156493
Wenger DA Diagnosis of atypical patients with lipid storage diseases. 1985 Brain Dev. pmid:4014607
Li SC et al. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide. 1985 J. Biol. Chem. pmid:2981875
Dawson G et al. Regulation of GM2 ganglioside metabolism in cultured cells. 1986 Chem. Phys. Lipids pmid:3549015
Wynn CH and Robson B Calculation of the conformation of glycosphingolipids. 2. GM1- and GM2-gangliosides. 1986 J. Theor. Biol. pmid:3626589
Sugimoto M et al. Total synthesis of gangliosides GM1 and GM2. 1986 Carbohydr. Res. pmid:3815403
Natoli EJ et al. A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity. 1986 Cancer Res. pmid:3731079
Cavaillon JM et al. Ganglioside identification on human monocyte membrane with Clostridium perfringens delta-toxin. 1986 J. Leukoc. Biol. pmid:2872258
Zeigler M and Bach G Internalization of exogenous gangliosides in cultured skin fibroblasts for the diagnosis of mucolipidosis IV. 1986 Clin. Chim. Acta pmid:3087662
Charrow J and Binns HJ Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses. 1986 Clin. Chim. Acta pmid:2938852
Kotagal S et al. AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics. 1986 Neurology pmid:3081832
Dahiya R and Brasitus TA Glycosphingolipid patterns of fetal and adult small intestinal mucosa in the sheep. 1986 Biochim. Biophys. Acta pmid:3942764
Kotagal S Diagnosis of AB variant, GM2 gangliosidosis. 1986 Ann. Neurol. pmid:3080943
Miyagi T and Tsuiki S Evidence for sialidase hydrolyzing gangliosides GM2 and GM1 in rat liver plasma membrane. 1986 FEBS Lett. pmid:3758350
Oates CE et al. Movement disorders associated with chronic GM2 gangliosidosis. Case report and review of the literature. 1986 Eur. Neurol. pmid:3081350
Ishikawa Y et al. Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel. 1987 J. Neurochem. pmid:2949061
Li YT et al. Occurrence of ceramide-glycanase in the earthworm, Lumbricus terrestris. 1987 Biochem. Biophys. Res. Commun. pmid:3689409
Nagai K and Ishizuka I Biosynthesis of monosulfogangliotriaosylceramide and GM2 by N-acetylgalactosaminyltransferase from rat brain. 1987 J. Biochem. pmid:3115968
Naoi M et al. Ganglioside GM1 causes expression of type B monoamine oxidase in a rat clonal pheochromocytoma cell line, PC12h. 1987 J. Neurochem. pmid:3117976
Rosengren B et al. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease? 1987 J. Neurochem. pmid:3612128
Eto Y et al. Partial deficiency of beta-hexosaminidase activity in canine GM2-gangliosidosis. 1987 Tohoku J. Exp. Med. pmid:2958961
Yamanaka T et al. Detection of gangliotriaose-series glycosphingolipids in serum of cord blood and patients with neuroblastoma by a sensitive TLC/enzyme-immunostaining method. 1987 Biochim. Biophys. Acta pmid:3300782
Ando I et al. Ganglioside GM2 on the K562 cell line is recognized as a target structure by human natural killer cells. 1987 Int. J. Cancer pmid:3596830
Yanagisawa K et al. Purification and properties of GM2 synthase, UDP-N-acetylgalactosamine: GM3 beta-N-acetylgalactosaminyltransferase from rat liver. 1987 Biochim. Biophys. Acta pmid:3109491
Harding AE et al. Adult onset supranuclear ophthalmoplegia, cerebellar ataxia, and neurogenic proximal muscle weakness in a brother and sister: another hexosaminidase A deficiency syndrome. 1987 J. Neurol. Neurosurg. Psychiatry pmid:2956362
Livingston PO et al. Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients. 1987 Proc. Natl. Acad. Sci. U.S.A. pmid:3472242
Livingston PO et al. Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells. 1987 J. Immunol. pmid:3805726
Ilyas AA et al. Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy. 1988 J. Biol. Chem. pmid:2450092
Sanai Y et al. Monoclonal antibody directed to a Hanganutziu-Deicher active ganglioside, GM2 (NeuGc). 1988 Biochim. Biophys. Acta pmid:2449247
Jolivet-Reynaud C et al. Damaging effects of Clostridium perfringens delta toxin on blood platelets and their relevance to ganglioside GM2. 1988 Arch. Biochem. Biophys. pmid:3162668
Kushi Y et al. Direct analysis of glycolipids on thin-layer plates by matrix-assisted secondary ion mass spectrometry: application for glycolipid storage disorders. 1988 Anal. Biochem. pmid:3149874
Miyake M et al. Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides. 1988 Cancer Res. pmid:3167861
Tanaka A et al. GM2-gangliosidosis B1 variant: a wide geographic and ethnic distribution of the specific beta-hexosaminidase alpha chain mutation originally identified in a Puerto Rican patient. 1988 Biochem. Biophys. Res. Commun. pmid:2973311
Lichtenberg P et al. Post-partum psychosis in adult GM2 gangliosidosis. A case report. 1988 Br J Psychiatry pmid:2977954
Budde-Steffen C et al. Presence of beta-hexosaminidase A alpha-chain mRNA in two different variants of GM2-gangliosidosis. 1988 Neuropediatrics pmid:2967444
Torres BV et al. Glycolipid-lectin interactions: reactivity of lectins from Helix pomatia, Wisteria floribunda, and Dolichos biflorus with glycolipids containing N-acetylgalactosamine. 1988 Arch. Biochem. Biophys. pmid:3355161
Naoi M et al. Specific binding of glycosylated beta-galactosidase to rat clonal pheochromocytoma PC12h cells: effects of nerve growth factor and gangliosides. 1988 J. Neurochem. pmid:3126266
DeGasperi R et al. A GM2-specific beta-hexosaminidase from the roe of striped mullet (Mugil cephalus). 1988 J. Biol. Chem. pmid:2961751
Ohno K and Suzuki K Mutation in GM2-gangliosidosis B1 variant. 1988 J. Neurochem. pmid:2961848
Baba H et al. Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy. 1989 J. Neuroimmunol. pmid:2584393
Singer HS and Cork LC Canine GM2 gangliosidosis: morphological and biochemical analysis. 1989 Vet. Pathol. pmid:2540585
Livingston PO et al. Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside. 1989 Cancer Res. pmid:2582446
Zvezdina ND et al. Gangliosides of sea urchin embryos. Their localization and participation in early development. 1989 Eur. J. Biochem. pmid:2598928
Vrionis FD et al. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. 1989 Cancer Res. pmid:2479468
Ghidoni R et al. Metabolism of exogenous gangliosides in cerebellar granule cells, differentiated in culture. 1989 J. Neurochem. pmid:2795018
Dotta F et al. Ganglioside expression in human pancreatic islets. 1989 Diabetes pmid:2695376
Fredman P et al. A new ganglioside of the lactotetraose series, GalNAc-3'-isoLM1, detected in human meconium. 1989 J. Biol. Chem. pmid:2473071
Schröder M et al. Isolation of a cDNA encoding the human GM2 activator protein. 1989 FEBS Lett. pmid:2753159
DeGasperi R et al. Isolation and characterization of an activator protein for the hydrolysis of ganglioside GM2 from the roe of striped mullet (Mugil cephalus). 1989 Biochem. J. pmid:2527497
Hoon DS et al. Ganglioside GM2 expression on human melanoma cells correlates with sensitivity to lymphokine-activated killer cells. 1989 Int. J. Cancer pmid:2714890
Riboni L et al. Formation of ganglioside GD1b-lactone in rat brain from intracisternally administered GD1b. 1989 J. Neurochem. pmid:2709011
Walton KM and Schnaar RL Coordinate regulation of ganglioside glycosyltransferases in differentiating NG108-15 neuroblastoma x glioma cells. 1989 J. Neurochem. pmid:2540274
Hechtman P et al. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese. 1989 Clin. Genet. pmid:2527097
Irie RF et al. Human monoclonal antibody to ganglioside GM2 for melanoma treatment. 1989 Lancet pmid:2564593
Paw BH et al. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase. 1989 Proc. Natl. Acad. Sci. U.S.A. pmid:2522660
Mitsuo K et al. Juvenile Sandhoff disease: a Japanese patient carrying a mutation identical to that found earlier in a Canadian patient. 1990 J. Neurol. Sci. pmid:2147031
Yoshino H et al. Abnormal glycosphingolipid metabolism in the nervous system of galactosialidosis. 1990 J. Neurol. Sci. pmid:2115076
Hanisch FG et al. Glycosphingolipid expression on murine L1-fibrosarcoma cells: analysis of clonal in vivo and in vitro selected sublines with different lung colonisation potential. 1990 Br. J. Cancer pmid:2372482
Tonevitsky AG et al. Effect of gangliosides on binding, internalization and cytotoxic activity of ricin. 1990 FEBS Lett. pmid:2358071
Trinchera M and Ghidoni R Precursor-product relationship between GM1 and GD1a biosynthesized from exogenous GM2 ganglioside in rat liver. 1990 J. Biochem. pmid:2358435
Mahuran DJ et al. The molecular basis of Tay-Sachs disease: mutation identification and diagnosis. 1990 Clin. Biochem. pmid:2147596
Trinchera M et al. The N-acetylgalactosamine residue of exogenous GM2 ganglioside is recycled for glycoconjugate biosynthesis in rat liver. 1990 Biochem. J. pmid:2310367
Fürst W et al. The complete amino-acid sequences of human ganglioside GM2 activator protein and cerebroside sulfate activator protein. 1990 Eur. J. Biochem. pmid:2209618
Cantù L et al. Evidence for spontaneous segregation phenomena in mixed micelles of gangliosides. 1990 Chem. Phys. Lipids pmid:2289284
Paw BH et al. Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase. 1990 J. Biol. Chem. pmid:2140574
Dohi T et al. Sialylpentaosylceramide detected with anti-GM2 monoclonal antibody. Structural characterization and complementary expression with GM2 in gastric cancer and normal gastric mucosa. 1990 J. Biol. Chem. pmid:2139874
Yamaguchi H et al. Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient. 1990 Proc. Natl. Acad. Sci. U.S.A. pmid:2159145
Karlsson G et al. Characterization of the binding epitope of the monoclonal antibody DMAb-1 to ganglioside GM2. 1990 Biochim. Biophys. Acta pmid:1691018
Navon R et al. Ashkenazi-Jewish and non-Jewish adult GM2 gangliosidosis patients share a common genetic defect. 1990 Am. J. Hum. Genet. pmid:2278539
Miyake M et al. The abnormal occurrence and the differentiation-dependent distribution of N-acetyl and N-glycolyl species of the ganglioside GM2 in human germ cell tumors. A study with specific monoclonal antibodies. 1990 Cancer pmid:2153431
Nakamura K et al. Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. 1990 J. Biochem. pmid:2332419
Navon R Molecular and clinical heterogeneity of adult GM2 gangliosidosis. 1991 Dev. Neurosci. pmid:1840100
Suzuki K and Vanier MT Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype. 1991 Dev. Neurosci. pmid:1840099
Federico A et al. The clinical aspects of adult hexosaminidase deficiencies. 1991 Dev. Neurosci. pmid:1840098
Goodman LA et al. Ectopic dendrites occur only on cortical pyramidal cells containing elevated GM2 ganglioside in alpha-mannosidosis. 1991 Proc. Natl. Acad. Sci. U.S.A. pmid:1763046
Dohi T et al. Localization of UDP-GalNAc:NeuAc alpha 2,3Gal-R beta 1,4(GalNAc to Gal)N-acetylgalactosaminyltransferase in human stomach. Enzymatic synthesis of a fundic gland-specific ganglioside and GM2. 1991 J. Biol. Chem. pmid:1748676
Chen S et al. Quantitative analysis of the molecular species of monosialogangliosides by continuous-flow fast-atom bombardment mass spectrometry. 1991 Rapid Commun. Mass Spectrom. pmid:1811797
dos Santos MR et al. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene mutations in 11 patients from a defined region in Portugal. 1991 Am. J. Hum. Genet. pmid:1832817
Nakamura M et al. Radioimmune assay of sialyltransferase and N-acetylgalactosaminyltransferase activities using specific antibodies on a 96-well filtration plate of a multiscreen assay system. 1991 Anal. Biochem. pmid:1789418
Schröder M et al. A mutation in the gene of a glycolipid-binding protein (GM2 activator) that causes GM2-gangliosidosis variant AB. 1991 FEBS Lett. pmid:1915858
Klima H et al. Characterization of full-length cDNAs and the gene coding for the human GM2 activator protein. 1991 FEBS Lett. pmid:1915857
Bjerkvig R et al. Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line. 1991 Cancer Res. pmid:1873810
Xie B et al. Isolation and expression of a full-length cDNA encoding the human GM2 activator protein. 1991 Biochem. Biophys. Res. Commun. pmid:2059210
Hoffman LM et al. SV-40 transformation: effect on GM2 ganglioside in cultured cell lines. 1991 Biochim. Biophys. Acta pmid:1647206
Liu YB and Chan KF High-performance capillary electrophoresis of gangliosides. 1991 Electrophoresis pmid:1889389
Sindern E et al. Serum antibodies to GM1 and GM3-gangliosides in systemic lupus erythematosus with chronic inflammatory demyelinating polyradiculoneuropathy. 1991 Acta Neurol. Scand. pmid:1887763
Mahuran DJ The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis. 1991 Biochim. Biophys. Acta pmid:1825792
Meier EM et al. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A. 1991 J. Biol. Chem. pmid:1824846
Kono M et al. Two pathways for GM2(NeuGc) expression in mice: genetic analysis. 1991 J. Biochem. pmid:2016262
Yavin E et al. Nerve growth factor mediates monosialoganglioside-induced release of fibronectin and J1/tenascin from C6 glioma cells. 1991 J. Neurochem. pmid:1702827
Obi T et al. IgM M-protein in a patient with sensory-dominant neuropathy binds preferentially to polysialogangliosides. 1992 Acta Neurol. Scand. pmid:1384262
Schaeper RJ et al. In vitro biosynthesis of GbOse4Cer (globoside) and GM2 ganglioside by the (1-->3) and (1-->4)-N-acetyl beta-D-galactosaminyltransferases from embryonic chicken brain. Solubilization, purification, and characterization of the transferases. 1992 Carbohydr. Res. pmid:1291049
Xie B et al. Identification of a processed pseudogene related to the functional gene encoding the GM2 activator protein: localization of the pseudogene to human chromosome 3 and the functional gene to human chromosome 5. 1992 Genomics pmid:1427911
Nagata Y et al. Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides. 1992 J. Biol. Chem. pmid:1601877
Xie B et al. A Cys138-to-Arg substitution in the GM2 activator protein is associated with the AB variant form of GM2 gangliosidosis. 1992 Am. J. Hum. Genet. pmid:1570834
Dobrenis K et al. Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin. 1992 Proc. Natl. Acad. Sci. U.S.A. pmid:1532255
Renshaw PF et al. Electroconvulsive therapy treatment of depression in a patient with adult GM2 gangliosidosis. 1992 Ann. Neurol. pmid:1386210
Nakao T et al. Novel lacto-ganglio type gangliosides with GM2-epitope in bovine brain which react with IgM from a patient of the amyotrophic lateral sclerosis-like disorder. 1993 J. Biol. Chem. pmid:7691804
Yamashiro S et al. Genetic and enzymatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines. 1993 Cancer Res. pmid:8221677